Board of Scientific Counselors, National Center for Public Health Informatics: Notice of Charter Renewal, 65130-65131 [E9-29363]
Download as PDF
<![CDATA[
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
65130
Federal Register / Vol. 74, No. 235 / Wednesday, December 9, 2009 / Notices
United States, even though this behavior
will result in death or disability for half
of all regular users. Paralleling this
enormous health burden is the
economic burden of tobacco use, which
is estimated to total $193 billion
annually in medical expenditures and
lost productivity. Curbing the
significant adverse consequences of
tobacco use is one of the most important
public health goals of our time. One way
to do this is to prevent youth from
beginning to smoke. According to the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA’s)
National Survey on Drug Use and
Health, 80 percent of adults who are
nicotine dependent report that they
started smoking cigarettes before the age
of 18.
On June 22, 2009, the President
signed the Tobacco Control Act into
law. The Tobacco Control Act grants
FDA important new authority to
regulate the manufacture, marketing,
and distribution of tobacco products to
protect the public health generally and
to reduce tobacco use by minors.
Section 102 of the Tobacco Control Act
requires FDA to issue, with certain
modifications, its 1996 final regulation
restricting the sale and distribution of
cigarettes and smokeless tobacco
products (August 28, 1996, 61 FR 44396
at 44615 to 44618). The rule contains
provisions designed to limit young
people’s access to tobacco products, as
well as restrictions on marketing to curb
the appeal of these products to minors.
Section 103(q)(2) of the Tobacco
Control Act includes two schedules for
assessing civil money penalties against
retailers for violations of restrictions on
the sale and distribution of tobacco
products, including restrictions on
access to, and the promotion and
advertising of, tobacco products. Under
each schedule, violators are subject to
increasing penalties for repeated
violations within prescribed time
periods. For the first three violations in
a 24-month period, retailers with
approved training programs are subject
to lower penalties than retailers without
such programs. Section 103(q)(2)(B) of
the Tobacco Control Act defines
‘‘approved training program’’ as ‘‘a
training program that complies with
standards developed by the [FDA] for
such programs.’’
We are requesting comments that will
inform the development of guidance on
approved training programs. A copy of
the Family Smoking Prevention and
Tobacco Control Act is available on the
agency’s Web site at https://www.
fda.gov/TobaccoProducts/Guidance
ComplianceRegulatoryInformation/
default.htm.
VerDate Nov<24>2008
15:02 Dec 08, 2009
Jkt 220001
II. Request for Comments and
Information
We are interested in comments on the
characteristics that comprise an
effective training program for clerks
selling tobacco products in a retail
establishment. Such programs would
effectively teach such clerks how to
request and verify the photo
identification of purchasers younger
than 27 years of age and how to refuse
the sale of cigarettes or smokeless
tobacco to purchasers younger than 18
years of age. We are particularly
interested in information about
elements of current tobacco retailer
training programs developed by trade
associations, corporations, States and
localities, as well as any studies on the
effectiveness of these training programs
in reducing retail sales of tobacco
products to youth.
We believe that effective retailer
training programs may include many of
the following components and we
welcome input on any of these specific
elements:
• Methods for teaching salesclerks
about:
» Federal, State, and local laws
prohibiting youth access to tobacco.
» The health and societal costs of
tobacco use as the basis for youth
access laws.
» Company policies on youth access
to tobacco.
» The definition of tobacco products
covered by youth access laws.
» Laws and company policies on
requiring identification, including
the age that triggers ID verification
and the acceptable forms of ID.
» The need to closely examine ID,
including an explanation that many
illegal sales are made to minors
who produce IDs showing that they
are under the legal age to purchase
tobacco products.
» Verification of an ID’s authenticity,
including the features of an ID that
must be checked, how to tell if an
ID might have been altered and
what an employee should do if an
ID appears to be altered.
» The fact that salesclerks are not
required to make a tobacco sale if
there is any question that doing so
would violate the law.
• Specific age-verifying protocols
designed to ensure that the date of birth
is read, clearly understood, and
compared to a calendar or other age
verification device.
• Practical techniques for:
» Asking for ID.
» When and how to ask for a second
ID.
» Declining a sale when the customer
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
has no ID or when the ID shows the
customer to be underage.
» Declining a sale because of
concerns about whether the ID has
been altered.
» Declining purchase attempts by a
minor made with written parental
permission.
» Resisting customer pressure.
» Declining to sell tobacco to
underage persons who are friends,
acquaintances, and peer group
members and the techniques for
refusal.
• Methods for ensuring and
documenting that employees have the
knowledge required to comply with
youth access laws.
We also believe that effective
programs would include strategies for
initial training of new employees and
refresher training for existing
employees. We are interested in
learning about programs that address
both of these aspects, as well as
information related to the appropriate
length of time between initial and
refresher training, and the most
appropriate methods for training (e.g.,
in-person training, Web-based training,
self-study). The agency will consider
information submitted to the docket in
developing guidance on approved
training programs.
III. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) electronic or written
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Dated: December 3, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9–29288 Filed 12–8–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Public Health
Informatics: Notice of Charter Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
E:\FR\FM\09DEN1.SGM
09DEN1
Federal Register / Vol. 74, No. 235 / Wednesday, December 9, 2009 / Notices
463) of October 6, 1972, that the Board
of Scientific Counselors, National
Center for Public Health Informatics,
Department of Health and Human
Services, has been renewed for a 2-year
period through November 5, 2011.
For information, contact Scott
McNabb, Ph.D., Designated Federal
Officer, Board of Scientific Counselors,
National Center for Public Health
Informatics, Department of Health and
Human Services, 1600 Clifton Road,
NE., M/S E91, Atlanta, Georgia 30333,
Telephone 770/498–6427.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: December 3, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–29363 Filed 12–8–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of Laboratories Which
Meet Minimum Standards To Engage in
Urine Drug Testing for Federal
Agencies
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
AGENCY: Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
SUMMARY: The Department of Health and
Human Services (HHS) notifies Federal
agencies of the laboratories currently
certified to meet the standards of
Subpart C of the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines). The
Mandatory Guidelines were first
published in the Federal Register on
April 11, 1988 (53 FR 11970), and
subsequently revised in the Federal
Register on June 9, 1994 (59 FR 29908),
on September 30, 1997 (62 FR 51118),
and on April 13, 2004 (69 FR 19644).
A notice listing all currently certified
laboratories is published in the Federal
Register during the first week of each
month. If any laboratory’s certification
is suspended or revoked, the laboratory
will be omitted from subsequent lists
until such time as it is restored to full
VerDate Nov<24>2008
15:02 Dec 08, 2009
Jkt 220001
certification under the Mandatory
Guidelines.
If any laboratory has withdrawn from
the HHS National Laboratory
Certification Program (NLCP) during the
past month, it will be listed at the end,
and will be omitted from the monthly
listing thereafter.
This notice is also available on the
Internet at https://
www.workplace.samhsa.gov and https://
www.drugfreeworkplace.gov.
FOR FURTHER INFORMATION CONTACT: Mrs.
Giselle Hersh, Division of Workplace
Programs, SAMHSA/CSAP, Room 2–
1042, One Choke Cherry Road,
Rockville, Maryland 20857; 240–276–
2600 (voice), 240–276–2610 (fax).
SUPPLEMENTARY INFORMATION: The
Mandatory Guidelines were developed
in accordance with Executive Order
12564 and section 503 of Public Law
100–71. Subpart C of the Mandatory
Guidelines, ‘‘Certification of
Laboratories Engaged in Urine Drug
Testing for Federal Agencies,’’ sets strict
standards that laboratories must meet in
order to conduct drug and specimen
validity tests on urine specimens for
Federal agencies. To become certified,
an applicant laboratory must undergo
three rounds of performance testing plus
an on-site inspection. To maintain that
certification, a laboratory must
participate in a quarterly performance
testing program plus undergo periodic,
on-site inspections.
Laboratories which claim to be in the
applicant stage of certification are not to
be considered as meeting the minimum
requirements described in the HHS
Mandatory Guidelines. A laboratory
must have its letter of certification from
HHS/SAMHSA (formerly: HHS/NIDA)
which attests that it has met minimum
standards.
In accordance with Subpart C of the
Mandatory Guidelines dated April 13,
2004 (69 FR 19644), the following
laboratories meet the minimum
standards to conduct drug and specimen
validity tests on urine specimens:
ACL Laboratories, 8901 W. Lincoln
Ave., West Allis, WI 53227, 414–328–
7840/800–877–7016, (Formerly:
Bayshore Clinical Laboratory).
ACM Medical Laboratory, Inc., 160
Elmgrove Park, Rochester, NY 14624,
585–429–2264.
Advanced Toxicology Network, 3560
Air Center Cove, Suite 101, Memphis,
TN 38118, 901–794–5770/888–290–
1150.
Aegis Analytical Laboratories, 345 Hill
Ave., Nashville, TN 37210, 615–255–
2400, (Formerly: Aegis Sciences
Corporation, Aegis Analytical
Laboratories, Inc.).
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
65131
Baptist Medical Center-Toxicology
Laboratory, 9601 I–630, Exit 7, Little
Rock, AR 72205–7299, 501–202–2783,
(Formerly: Forensic Toxicology
Laboratory Baptist Medical Center).
Clinical Reference Lab, 8433 Quivira
Road, Lenexa, KS 66215–2802, 800–
445–6917.
Doctors Laboratory, Inc., 2906 Julia
Drive, Valdosta, GA 31602, 229–671–
2281.
DrugScan, Inc., P.O. Box 2969, 1119
Mearns Road, Warminster, PA 18974,
215–674–9310.
DynaLIFE Dx*, 10150–102 St., Suite
200, Edmonton, Alberta, Canada T5J
5E2, 780–451–3702/800–661–9876,
(Formerly: Dynacare Kasper Medical
Laboratories).
ElSohly Laboratories, Inc., 5 Industrial
Park Drive, Oxford, MS 38655, 662–
236–2609.
Gamma-Dynacare Medical
Laboratories*, A Division of the
Gamma-Dynacare Laboratory
Partnership, 245 Pall Mall Street,
London, ONT, Canada N6A 1P4, 519–
679–1630.
Kroll Laboratory Specialists, Inc., 1111
Newton St., Gretna, LA 70053, 504–
361–8989/800–433–3823, (Formerly:
Laboratory Specialists, Inc.).
Kroll Laboratory Specialists, Inc., 450
Southlake Blvd., Richmond, VA
23236, 804–378–9130, (Formerly:
Scientific Testing Laboratories, Inc.;
Kroll Scientific Testing Laboratories,
Inc.),
Laboratory Corporation of America
Holdings, 7207 N. Gessner Road,
Houston, TX 77040, 713–856–8288/
800–800–2387.
Laboratory Corporation of America
Holdings, 69 First Ave., Raritan, NJ
08869, 908–526–2400/800–437–4986,
(Formerly: Roche Biomedical
Laboratories, Inc.).
Laboratory Corporation of America
Holdings, 1904 Alexander Drive,
Research Triangle Park, NC 27709,
919–572–6900/800–833–3984,
(Formerly: LabCorp Occupational
Testing Services, Inc., CompuChem
Laboratories, Inc.; CompuChem
Laboratories, Inc., A Subsidiary of
Roche Biomedical Laboratory; Roche
CompuChem Laboratories, Inc., A
Member of the Roche Group).
Laboratory Corporation of America
Holdings, 1120 Main Street,
Southaven, MS 38671, 866–827–8042/
800–233–6339, (Formerly: LabCorp
Occupational Testing Services, Inc.;
MedExpress/National Laboratory
Center).
LabOne, Inc. d/b/a Quest Diagnostics,
10101 Renner Blvd., Lenexa, KS
66219, 913–888–3927/800–873–8845,
(Formerly: Quest Diagnostics
E:\FR\FM\09DEN1.SGM
09DEN1
]]>Agencies
[Federal Register Volume 74, Number 235 (Wednesday, December 9, 2009)]
[Notices]
[Pages 65130-65131]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-29363]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Public Health
Informatics: Notice of Charter Renewal
This gives notice under the Federal Advisory Committee Act (Pub. L.
92-
[[Page 65131]]
463) of October 6, 1972, that the Board of Scientific Counselors,
National Center for Public Health Informatics, Department of Health and
Human Services, has been renewed for a 2-year period through November
5, 2011.
For information, contact Scott McNabb, Ph.D., Designated Federal
Officer, Board of Scientific Counselors, National Center for Public
Health Informatics, Department of Health and Human Services, 1600
Clifton Road, NE., M/S E91, Atlanta, Georgia 30333, Telephone 770/498-
6427.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: December 3, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-29363 Filed 12-8-09; 8:45 am]
BILLING CODE 4163-18-P
